Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age

Author: The Kaiser-UCLA Vaccine Study Group   Greenberg D.P.   Vadheim C.M.   Marcy S.M.   Partridge S.   Jing J.   Chung-Yin C.   Greene T.   Margolis H.S.   Ward J.I.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.14, Iss.8, 1996-06, pp. : 811-816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content